Bacterial Vaginosis: A Comprehensive Approach to Management in Reproductive-Aged Thai Women
Article Sidebar
Main Article Content
Abstract
Bacterial vaginosis (BV) is the predominant condition of vaginal dysbiosis leading women to seek gynecologic care. Excessive genital cleansing, particularly through vaginal douching, appears to be a precipitating factor. BV does not induce any inflammatory response, with more than half of patients remaining asymptomatic. The chief complaints are an increased vaginal discharge volume and an altered odor. BV compromises the body’s natural defense mechanisms, thereby increasing susceptibility to local and ascending infections. BV also heightens the risk of sexually transmitted infections, including pelvic inflammatory disease. For many years before 2022, our institution employed a metronidazole regimen of 1,200 mg daily, which demonstrated favorable efficacy. Metronidazole commonly leads to side effects such as nausea, vomiting, and a metallic taste. Unfortunately, many women discontinue the medication once their symptoms alleviate, as they often perceive BV as a vaginal imbalance rather than an infectious disease. In 2022, the Royal Thai College of Obstetricians and Gynaecologists introduced a recommended treatment guideline for BV that emphasized a balanced approach to medications and lifestyle modifications. Consequently, the primary antibiotic now used in Thailand is metronidazole, administered as a single 2 g dose or 800 mg daily for 7 days. At the Siriraj Female Sexually Transmitted Infections Clinic, we have utilized various metronidazole treatment regimens accompanied by comprehensive educational sessions and counseling. This article shows a comprehensive approach to management of BV in reproductive-aged Thai women, particularly based on Siriraj experience.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Chayachinda C, Chinhiran K, Kittiyaowamarn R, Chaithongwongwatthana S, Teeratakulpisarn N. The Thai 2022 sexually transmitted infections treatment guideline: Abnormal vaginal discharge. Thai J Obstet Gynaecol 2022:222-33.
Chayachinda C, Thamkhantho M, Chalermchockcharoenkit A, Neungton C, Thipmontree W. Characteristics of clients at the Siriraj female STD clinic during 2011-2015. Siriraj Med Bull 2018;11:182-9.
Ravel J, Moreno I, Simón C. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol 2021;224:251-7.
Tachawatcharapunya S, Chayachinda C, Parkpinyo N. The prevalence of bacterial vaginosis in asymptomatic pregnant women during early third trimester and the pregnancy complications. Thai J Obstet Gynaecol 2017;25:96-103.
Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. J Physiol 2017;595:451-63.
Witkin SS, Mendes-Soares H, Linhares IM, Jayaram A, Ledger WJ, Forney LJ. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. mBio 2013;4:e00460-13.
Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes J, et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 2001;185:375-9.
Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010;5:e10197.
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
Amsel R, Totten P, Spiegel C, Chen K, Eschenbach D, Holmes K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
Chayachinda C, Baukaew L, Thamkhantho M, Bangpichet A, Sodsee S, Pharkjaksu S. Clue cell as a single diagnostic tool for bacterial vaginosis during pregnancy. J Med Assoc Thai 2020;103:353-8.
Workowski K, Bachmann L, Chan P, Johnston C, Muzny C, Park I, et al. Sexually transmitted infections treatment guidelines 2021. MMWR Recomm Rep 2021;70:1-187.
Sherrard J, Wilson J, Donders G, Mendling W, Jensen J. 2018 European (IUSTI/WHO) International Union against Sexually Transmitted Infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. International Journal of STD & AIDs 2018;29:1258-72.
Royal Thai College of Obstetrics and Gynaecologists. Management of abnormal vaginal discharge in reproductive-aged women. Siriraj Med Bull 2023;16:187-29.
Kardas P, Devine S, Golembesky A, Roberts C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J Antimicrob Agents 2005;26:106-13.
Aslan E, Bechelaghem N. To ‘douche’ or not to ‘douche’: hygiene habits may have detrimental effects on vaginal microbiota. J Obstet Gynaecol 2018;38: 678-81.
Hosiriphon K, Chayachinda C, Keawpoonsub K, Taibowornpitak K, Tuangrattanasirikun D. A survey of daily genital care practices among reproductive-aged female personnel at Siriraj Hospital. Siriraj Med J 2023;75:259-65.
Thamkhantho M, Chayachinda C, Lertaroonchai C. Vaginal suppository of metronidazole (750mg) plus miconazole nitrate (200mg) versus oral metronidazole (2g) for bacterial vaginosis: A randomized controlled trial. Siriraj Med J 2021;73:644-51.
Crann S, Cunningham S, Albert A, Money D, O’Doherty K. Vaginal health and hygiene practices and product use in Canada: a national cross-sectional survey. BMC Womens Health 2018;18:52.
Chaithongwongwatthana S, Limpongsanurak S, Sitthi-Amorn C. Single hydrogen peroxide vaginal douching versus single-dose oral metronidazole for the treatment of bacterial vaginosis: a randomized controlled trial. J Med Assoc Thai 2003;86 Suppl 2:S379-84.
Mendling W, Shazly M, Zhang L. The role of lactic acid in the management of bacterial vaginosis: a systematic literature review. Future Pharmacology 2022;2:198-213.
Armstrong E, Hemmerling A, Miller S, Burke K, Newmann S, Morris S, et al. Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli. J Clin Invest 2022;132:e152930.
Decena D, Co J, Manalastas RJ, Palaypayon E, Padolina C, Sison J, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res 2006;32:243-51.
Andersch B, Forssman L, Lincoln K, Torstensson P. Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol Obstet Invest 1986;21:19-25.
Faught B, Reyes S. Characterization and Treatment of Recurrent Bacterial Vaginosis. J Womens Health (Larchmt) 2019;28:1218-26.
Gaspar C, Rolo J, Cerca N, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A. Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms. Pathogens 2021;10:261.
Donders G, Van Bulck B, Van de Walle P, Kaiser R, Pohli G, Gonser S, et al. Effect of Lyophilized Lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: A multicenter, randomized, single-blind, active-controlled pilot study subject area: Further areas women’s and children’s health. Gynecol Obstet Invest 2010;70:264-72.
Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson F, et al. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 1996;46:68-73.
Leetanaporn R, Chandeying V, Tungphaisal S. The efficacy of oral clindamycin in the treatment of bacterial vaginosis. Thai J Obstet Gynaecol 1994;6: 91-9.
Marrazzo JM, Handsfield HH, Whittington WL. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 2002;100:579-84.